164 related articles for article (PubMed ID: 6364796)
21. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and insulin receptors in hepatic cirrhosis.
Blei AT; Robbins DC; Drobny E; Baumann G; Rubenstein AH
Gastroenterology; 1982 Dec; 83(6):1191-9. PubMed ID: 6751926
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glucagon secretion by crude liver extract in conscious dogs.
Kabadi UM
Diabetes Res; 1993; 23(1):41-6. PubMed ID: 7924147
[TBL] [Abstract][Full Text] [Related]
24. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
25. Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
Dudley FJ; Alford FP; Chisholm DJ; Findlay DM
Gut; 1979 Oct; 20(10):817-24. PubMed ID: 533693
[TBL] [Abstract][Full Text] [Related]
26. The association of hepatic glycogen depletion with hyperammonemia in cirrhosis.
Kabadi UM
Hepatology; 1987; 7(5):821-4. PubMed ID: 3308664
[TBL] [Abstract][Full Text] [Related]
27. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
[TBL] [Abstract][Full Text] [Related]
28. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
Hamberg O
Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
[TBL] [Abstract][Full Text] [Related]
29. [Behavior of circulating somatostatin in cirrhotic subjects: correlation with hepatic function].
Tanganelli I; Signorini AM; Gragnoli G
Boll Soc Ital Biol Sper; 1988 Mar; 64(3):251-6. PubMed ID: 2903752
[No Abstract] [Full Text] [Related]
30. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
Flisiak R; Pytel-Krolczuk B; Prokopowicz D
Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
Dupre J; Caussignac Y; McDonald TJ; Van Vliet S
J Clin Endocrinol Metab; 1991 Jan; 72(1):125-9. PubMed ID: 1986010
[TBL] [Abstract][Full Text] [Related]
32. Physiology of glucagon.
Gerich JE
Int Rev Physiol; 1981; 24():243-75. PubMed ID: 7021445
[TBL] [Abstract][Full Text] [Related]
33. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
[TBL] [Abstract][Full Text] [Related]
34. Glucagon and insulin metabolism in cirrhotic patients.
Yoshida T; Ninomiya K; Matsumoto T; Baatar D; Bandoh T; Kitano S
Hepatogastroenterology; 1998; 45(20):468-71. PubMed ID: 9638429
[TBL] [Abstract][Full Text] [Related]
35. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels.
Sohara N; Takagi H; Kakizaki S; Sato K; Mori M
Liver Int; 2005 Feb; 25(1):28-32. PubMed ID: 15698395
[TBL] [Abstract][Full Text] [Related]
36. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F
Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944
[No Abstract] [Full Text] [Related]
37. Glucose resistance contributes to diabetes mellitus in cirrhosis.
Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
[TBL] [Abstract][Full Text] [Related]
38. [Effect of glucagon on blood gastrin levels in hepatic cirrhosis: correlation with blood levels of cyclic AMP].
Francavilla A; Sansonno D; Ierardi E; Amoruso A
Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2588-93. PubMed ID: 6258616
[TBL] [Abstract][Full Text] [Related]
39. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
[TBL] [Abstract][Full Text] [Related]
40. [Hyperglucagonemia in liver cirrhosis: relationship to hepatic dysfunction and portal systemic shunt (author's transl)].
Tsubouchi H; Kamibeppu A; Fujisaki K; Nagahama S; Kubosono O
Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2193. PubMed ID: 7328842
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
